Clinical Trials Browser

OTHER × Carcinoma, Renal Cell × G250 monoclonal antibody × Clear all

NCT00520533 2022-10-12

Study of Safety and Functional Imaging of cG250 and Sunitinib in Patients With Advanced Renal Cell Carcinoma

Phase 1 Terminated

8 enrolled 18 charts

Carcinoma, Renal Cell, Mycobacterium Infections, Nontuberculous

NCT02883153 2017-06-19

Zirconium-89-girentuximab PET/CT Imaging in Renal Cell Carcinoma

Phase 2/3 Completed

Carcinoma, Renal Cell

NCT00602862 2013-12-02

Effect of Sorafenib on ccRCC Uptake of Radiolabeled Bevacizumab or cG250

Phase NA Completed

Carcinoma, Renal Cell